GOTAVIQ

Serial Number 90430272
606

Registration Progress

Application Filed
Dec 30, 2020
Under Examination
Oct 5, 2021
Approved for Publication
Aug 10, 2021
Published for Opposition
Aug 10, 2021
Registered

Trademark Image

GOTAVIQ

Basic Information

Serial Number
90430272
Filing Date
December 30, 2020
Published for Opposition
August 10, 2021
Abandonment Date
May 9, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 9, 2022
Classes
005

Rights Holder

Applied Therapeutics, Inc.

03
Address
545 Fifth Avenue, Suite 1400
New York, NY 10173

Ownership History

Applied Therapeutics, Inc.

Original Applicant
03
New York, NY

Applied Therapeutics, Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Anna Kurian Shaw

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
May 9, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 9, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 5, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 10, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 10, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 21, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 2, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 1, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 24, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 31, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 31, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 31, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 31, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 31, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 2, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) and PMM2-congential disorder of glycosylation (PMM2-CDG)

Classification

International Classes
005